Alzheimer's disrupts circadian rhythms of plaque-clearing brain cells

October 21, 2025 Woodard elected to National Academy of MedicineHead of radiology recognized for leadership in radiology and advancing cardiac imaging techniques.National Leaders, News Release

October 9, 2025 WashU Medicine’s fellow-to-faculty programs nurture growth of talented early-career scientistsDevoted mentors, immense tech resources fast-track scientific independence.Medical Campus & Community

October 7, 2025 A promise to future patientsIn rite of passage, first-year medical students receive their white coats and, together, recite a shared oath.Medical Campus & Community, School of Medicine, Video

Researchers from Washington University School of Medicine in St. Louis have now shown in mice that the circadian rhythms within particular brain cells are disrupted in Alzheimer’s disease in ways that change how and when hundreds of genes regulate key functions in the brain.

The findings, published October 23 in Nature Neuroscience, suggest that controlling or correcting these circadian rhythms could be a potential way to treat the disease.

Musiek had previously identified a specific protein, YKL-40, that fluctuates across the circadian cycle and regulates normal levels of amyloid protein in the brain. He found that too much of YKL-40, which is linked to Alzheimer’s risk in humans, leads to amyloid build-up, an accumulation that is a hallmark of the neurodegenerative disease.

While the circadian disruption didn’t entirely shut down the genes in question, it turned an orderly sequence of events into a scattershot affair that could degrade the optimal synchronicity of brain cells’ functions, such as clearing amyloid.

In addition, the researchers found that the presence of amyloid appeared to create new rhythms in hundreds of genes that do not typically have a circadian pattern of activity. Many of the genes are involved in the brain’s inflammatory response to infection or imbalances such as amyloid plaque build-up.

Musiek said that altogether the findings point to exploring therapies that target circadian cycles in microglia and astrocytes to support healthy brain function.

“We have a lot of things we still need to understand, but where the rubber meets the road is trying to manipulate the clock in some way, make it stronger, make it weaker or turn it off in certain cell types,” he said. “Ultimately, we hope to learn how to optimize the circadian system to prevent amyloid accumulation and other aspects of Alzheimer’s disease.”

In rite of passage, first-year medical students receive their white coats and, together, recite a shared oath.

Alzheimer’s disease is notorious for scrambling patients’ daily rhythms. Restless nights with little sleep and increased napping during the day are early indicators of disease onset, while sundowning, or confusion later in the day, is typical for later stages of the disease. These symptoms suggest a link between the progression of the disease and the circadian system — the body’s internal clock that controls our sleep and wake cycle — but scientists did not know the full nature of the connection.

The cyclic nature of Alzheimer’s symptoms suggests that there are more circadian-regulated proteins and their associated genes involved beyond YKL-40. So in this latest study, Musiek and his colleagues examined gene expression in the brains of mice with accumulations of amyloid proteins that mimic early stages of Alzheimer’s, as well as those of both healthy, young animals and aged mice without amyloid accumulations. The scientists collected tissue at 2-hour intervals over 24 hours and then performed an analysis of what genes were active during particular phases of the circadian cycle.

They found that the amyloid accumulations threw off the daily rhythms of hundreds of genes in brain cells known as microglia and astrocytes in ways that were different from what aging alone caused. Microglia are part of the brain’s immune response, clearing away toxic materials and dead cells, while astrocytes have roles in supporting and maintaining communication between neurons. The affected genes are generally involved in helping microglial cells break down waste material from the brain, including amyloid.

October 21, 2025 Woodard elected to National Academy of MedicineHead of radiology recognized for leadership in radiology and advancing cardiac imaging techniques.National Leaders, News Release

Head of radiology recognized for leadership in radiology and advancing cardiac imaging techniques.

Devoted mentors, immense tech resources fast-track scientific independence.

Medical Campus & Community, School of Medicine, Video

Musiek, the co-director of the Center on Biological Rhythms and Sleep (COBRAS) at WashU Medicine and a neurologist who specializes in aging and dementia, said that changes in sleep patterns are among the most frequent concerns reported to him by caregivers of Alzheimer’s patients. He and colleagues have previously shown that these changes begin in Alzheimer’s years before memory loss becomes apparent. He noted that in addition to creating burdens for caregivers and patients, disrupted sleep patterns generate biological and psychological stresses that accelerate the progression of the disease.

October 21, 2025 Woodard elected to National Academy of MedicineHead of radiology recognized for leadership in radiology and advancing cardiac imaging techniques.National Leaders, News Release October 9, 2025 WashU Medicine’s fellow-to-faculty programs nurture growth of talented early-career scientistsDevoted mentors, immense tech resources fast-track scientific independence.Medical Campus & Community October 7, 2025 A promise to future patientsIn rite of passage, first-year medical students receive their white coats and, together, recite a shared oath.Medical Campus & Community, School of Medicine, Video